Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Block vs General Anesthesia in Mastectomy
NCT02065947Phase 2Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Oct 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection and Lidocaine Hydrochloride Injection, without epinephrine in breast cancer (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: Postoperative Analgesia Requirement (Opioids + Nonsteroidal Antiinflammatory Drug) at 24 hours. Started Oct 2013; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02065947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065947.